Login / Signup

Effect of Oligo-Fucoidan, Fucoxanthin, and L-Carnitine on Chronic Kidney Disease in Dogs: A Retrospective Study.

Naeun HongJu-Hyun AnSung-Soo KimSu-Min ParkGa-Hyun LimYe-In OhKyoung-Won SeoHwa-Young Youn
Published in: Animals : an open access journal from MDPI (2024)
Chronic kidney disease (CKD) commonly occurs in old dogs and cats. Oligo-fucoidan, fucoxanthin, and L-carnitine (OFL) compounds have a variety of reno-protective properties, including anti-inflammatory, anti-oxidative, and anti-fibrotic effects. Because their effects have not been investigated in naturally occurring canine CKD, we examined their reno-protective activities in dog patients with CKD. A total of 50 patients (OFL, n = 28; control, n = 22) were included in the analysis. A significant difference was identified in serum blood urea nitrogen and creatinine concentrations between the control and OFL groups at 6 months. No significant difference in electrolytes was found between the groups. A significant difference was identified in serum creatinine concentration between the control and OFL groups in azotemic (CKD IRIS stage 2-4) at 6 months. The OFL compounds showed a reno-protective effect, consistent with previous animal studies. The OFL combination can potentially delay the progression of canine CKD and be used as an adjuvant therapy.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • anti inflammatory
  • uric acid
  • ionic liquid
  • metabolic syndrome
  • patient reported outcomes
  • single molecule
  • high speed
  • patient reported